Back to Search
Start Over
Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation
- Source :
- Chinese Medical Journal. 136:848-850
- Publication Year :
- 2023
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2023.
- Subjects :
- General Medicine
Subjects
Details
- ISSN :
- 25425641 and 03666999
- Volume :
- 136
- Database :
- OpenAIRE
- Journal :
- Chinese Medical Journal
- Accession number :
- edsair.doi...........e5ee73e7577dc84ed322b667711bc9a5
- Full Text :
- https://doi.org/10.1097/cm9.0000000000002453